| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.009 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.009 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |